Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANTX
#3609
AN2 Therapeutics, Inc. Common Stock
1.1
0
+1.85%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+1.85%
Monthly Change
-7.56%
6 month change
-3.51%
Cambio anual
+0.92%
Cierres anteriores
1.0
8
Open
1.1
0
Bid
Ask
Low
1.1
0
High
1.1
0
Volumen
1
Markets
Acciones
Atención Sanitaria
ANTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2022
2023
2024
TTM
Key stats
Total common shares outstanding
19.4 M
29.77 M
30.1 M
—
Valuation ratios
Enterprise value
161.39 M
575.94 M
20.14 M
68.74 M
Price to earnings ratio
-3.48
-7.25
-0.8
-3.67
Price to sales ratio
—
—
—
—
Price to cash flow ratio
4.46
8.8
0.84
3.97
Price to book ratio
1.56
3.76
0.5
0.86
Enterprise value to EBITDA ratio
—
—
—
—
Profitability ratios
Return on assets %
0.4
0.47
0.56
0.01
Return on equity %
0.43
0.52
0.63
0.01
Return on invested capital %
2 741.62
1 425.16
1 149
—
Gross margin %
—
—
—
—
Operating margin %
—
—
—
—
EBITDA margin %
—
—
—
—
Net margin %
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
13.72
7.87
10.07
43.56
Inventory turnover
—
—
—
—
Asset turnover
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
Per share metrics
Operating cash flow per share
-2.18
-2.26
-1.65
-0.99
EBIT per share
—
—
—
—
EBITDA per share
—
—
—
—
Total debt per share
—
—
—
—
Cash per share
6.47
4.54
2.8
9.17
Net current asset value per share
6.43
4.68
2.89
9.56
Tangible book value per share
6.22
5.28
2.74
9.46
Working capital per share
5.96
4.09
2.6
8.66
Book value per share
6.22
5.28
2.74
9.46
Noticias
AN2 Therapeutics nombra a Sarah Williams como directora principal de contabilidad
AN2 Therapeutics nombra a Sarah Williams como directora principal de contabilidad
AN2 Therapeutics appoints Sarah Williams as principal accounting officer
La FDA aprueba el IND para ensayo de epetraborole en mycobacterium abscessus
FDA clears IND for epetraborole trial in mycobacterium abscessus
AN2 Therapeutics (ANTX) Upgraded to Buy: What Does It Mean for the Stock?
Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year?
AN2 Therapeutics (ANTX): CFO Day vende acciones por $8883
CFO de An2 Therapeutics vende acciones por 8.883 dólares
An2 therapeutics (ANTX): cfo Day sells $8883 in shares
Director de estrategia de An2 Therapeutics vende acciones por 6.507 dólares
CSO de AN2 Therapeutics vende acciones por $6,507